IBDEI0G3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7753,1,3,0)
 ;;=3^Spondylitis,Ankylosing
 ;;^UTILITY(U,$J,358.3,7753,1,4,0)
 ;;=4^720.0
 ;;^UTILITY(U,$J,358.3,7753,2)
 ;;=^113484
 ;;^UTILITY(U,$J,358.3,7754,0)
 ;;=743.10^^49^561^66
 ;;^UTILITY(U,$J,358.3,7754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7754,1,3,0)
 ;;=3^Microphthalmos,Unspec
 ;;^UTILITY(U,$J,358.3,7754,1,4,0)
 ;;=4^743.10
 ;;^UTILITY(U,$J,358.3,7754,2)
 ;;=^77633
 ;;^UTILITY(U,$J,358.3,7755,0)
 ;;=996.89^^49^561^52
 ;;^UTILITY(U,$J,358.3,7755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7755,1,3,0)
 ;;=3^Graft Rejection
 ;;^UTILITY(U,$J,358.3,7755,1,4,0)
 ;;=4^996.89
 ;;^UTILITY(U,$J,358.3,7755,2)
 ;;=^276309
 ;;^UTILITY(U,$J,358.3,7756,0)
 ;;=077.3^^49^561^26
 ;;^UTILITY(U,$J,358.3,7756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7756,1,3,0)
 ;;=3^Conjunctivitis,Adenoviral
 ;;^UTILITY(U,$J,358.3,7756,1,4,0)
 ;;=4^077.3
 ;;^UTILITY(U,$J,358.3,7756,2)
 ;;=^266673
 ;;^UTILITY(U,$J,358.3,7757,0)
 ;;=077.99^^49^561^21
 ;;^UTILITY(U,$J,358.3,7757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7757,1,3,0)
 ;;=3^Conjunctivitis d/t Virus,Unspec
 ;;^UTILITY(U,$J,358.3,7757,1,4,0)
 ;;=4^077.99
 ;;^UTILITY(U,$J,358.3,7757,2)
 ;;=^295786
 ;;^UTILITY(U,$J,358.3,7758,0)
 ;;=077.98^^49^561^9
 ;;^UTILITY(U,$J,358.3,7758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7758,1,3,0)
 ;;=3^Conjuctivitis d/t Chlamydiae
 ;;^UTILITY(U,$J,358.3,7758,1,4,0)
 ;;=4^077.98
 ;;^UTILITY(U,$J,358.3,7758,2)
 ;;=^295785
 ;;^UTILITY(U,$J,358.3,7759,0)
 ;;=190.4^^49^561^40
 ;;^UTILITY(U,$J,358.3,7759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7759,1,3,0)
 ;;=3^Cornea Malig Neopl
 ;;^UTILITY(U,$J,358.3,7759,1,4,0)
 ;;=4^190.4
 ;;^UTILITY(U,$J,358.3,7759,2)
 ;;=^267275
 ;;^UTILITY(U,$J,358.3,7760,0)
 ;;=V67.09^^49^562^22
 ;;^UTILITY(U,$J,358.3,7760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7760,1,3,0)
 ;;=3^F/U Vitreous Surgery
 ;;^UTILITY(U,$J,358.3,7760,1,4,0)
 ;;=4^V67.09
 ;;^UTILITY(U,$J,358.3,7760,2)
 ;;=F/U Vitreous Surgery^322080^V45.69^V43.1
 ;;^UTILITY(U,$J,358.3,7761,0)
 ;;=367.4^^49^562^44
 ;;^UTILITY(U,$J,358.3,7761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7761,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,7761,1,4,0)
 ;;=4^367.4
 ;;^UTILITY(U,$J,358.3,7761,2)
 ;;=Presbyopia^98095
 ;;^UTILITY(U,$J,358.3,7762,0)
 ;;=379.21^^49^562^43
 ;;^UTILITY(U,$J,358.3,7762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7762,1,3,0)
 ;;=3^Posterior Vitreous Detachment
 ;;^UTILITY(U,$J,358.3,7762,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,7762,2)
 ;;=^269309
 ;;^UTILITY(U,$J,358.3,7763,0)
 ;;=374.10^^49^562^20
 ;;^UTILITY(U,$J,358.3,7763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7763,1,3,0)
 ;;=3^Ectropion
 ;;^UTILITY(U,$J,358.3,7763,1,4,0)
 ;;=4^374.10
 ;;^UTILITY(U,$J,358.3,7763,2)
 ;;=Ectropion^38326
 ;;^UTILITY(U,$J,358.3,7764,0)
 ;;=373.00^^49^562^8
 ;;^UTILITY(U,$J,358.3,7764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7764,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,7764,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,7764,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,7765,0)
 ;;=250.00^^49^562^13
 ;;^UTILITY(U,$J,358.3,7765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7765,1,3,0)
 ;;=3^DM II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,7765,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,7765,2)
 ;;=DM Type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,7766,0)
 ;;=250.50^^49^562^12
 ;;^UTILITY(U,$J,358.3,7766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7766,1,3,0)
 ;;=3^DM II w/PDR
 ;;^UTILITY(U,$J,358.3,7766,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7766,2)
 ;;=DM II w/PDR^267839^362.02
